Licensure of gemtuzumab ozogamicin for the treatment of selected patients 60 years of age or older with acute myeloid leukemia in first relapse.

Source:http://linkedlifedata.com/resource/pubmed/id/12448657

Download in:

View as

General Info

PMID
12448657